← board
JUSHF
distress 2/10 · well-funded / low risk$0.43-2%today-49% from 52w high
Revenue
$66M
Liquidity
$40M
Runway
—
Shares 1y
+2%
Price & events
-25.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.8%
1D
-5.4%
1W
-5.0%
1M
-29.8%
3M
-25.1%
6M
+0.0%
1Y
-26.3%
2Y
-91.6%
5Y
-92.7%
All
Overview
- Market Cap
- $86.87M
- Enterprise Value
- $265.63M
- Volume
- 37.30K
- 52 Week Range
- $0.35 – $0.86
- Total Shares
- 199.70M
- Float Shares
- 173.72M
- % Held by Insiders
- 18.40%
- % Held by Institutions
- 11.09%
- RVOL
- 0.27x
- Beta
- 0.86
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-07-28Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- 2026-07-22 - GlobeNewswire
- 2026-07-22Jushi Holdings Inc. to report Q2 2026 results on July 28 - scanx.trade
- 2026-07-21Jushi Holdings Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026 - The Manila Times
- 2026-07-21Jushi Holdings Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026 - GlobeNewswire
- 2026-07-21Jushi Holdings Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026 - Caledon Enterprise
- 2026-07-21Jushi’s Q2 Results Webcast Will Stay Online Through Aug. 28 - Stock Titan
- 2026-07-21Jushi Holdings Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026 - Yahoo! Finance Canada
- 2026-06-25Jushi Holdings Inc. Announces Voting Results of Annual General and Special Shareholders’ Meeting - The Manila Times
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.